Gritstone bio, Inc.
GRTS · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,396 | -$40,385 | -$30,818 | -$38,434 |
| Dep. & Amort. | $1,600 | $1,742 | $1,921 | $1,964 |
| Deferred Tax | $0 | $0 | $1,394 | -$591 |
| Stock-Based Comp. | $3,467 | $3,246 | $2,823 | $2,964 |
| Change in WC | -$7,320 | -$3,275 | -$14,219 | -$808 |
| Other Non-Cash | $8,994 | $8,287 | $4,524 | $3,818 |
| Operating Cash Flow | -$26,811 | -$33,567 | -$34,375 | -$31,087 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$32 | -$143 | -$191 | -$1,093 |
| Net Acquisitions | $0 | $0 | $68,427 | -$19,374 |
| Inv. Purchases | -$2,699 | -$382 | -$3,614 | -$4,867 |
| Inv. Sales/Matur. | $1,846 | $12,828 | $42,100 | $24,241 |
| Other Inv. Act. | -$853 | $12,446 | -$68,427 | $19,374 |
| Investing Cash Flow | -$885 | $12,303 | $38,295 | $18,281 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$62 | -$62 | $9,896 | -$60 |
| Stock Issued | $38,143 | $45 | $5,488 | $0 |
| Stock Repurch. | $0 | -$788 | $0 | -$204 |
| Dividends Paid | $0 | $0 | -$742 | $0 |
| Other Fin. Act. | -$2,448 | -$317 | $1,075 | -$204 |
| Financing Cash Flow | $35,633 | -$379 | $30,584 | -$264 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,532 | -$21,643 | $34,504 | -$13,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43,642 | $65,285 | $30,781 | $49,141 |
| End Cash | $52,174 | $43,642 | $65,285 | $36,071 |
| Free Cash Flow | -$26,843 | -$33,710 | -$34,566 | -$32,180 |